BREWIN DOLPHIN LTD - ELOXX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$24
-20.0%
150.0%0.00%
Q2 2021$30
-40.0%
150.0%0.00%
Q1 2021$50
-16.7%
150.0%0.00%
Q4 2020$60
+53.8%
150.0%0.00%
Q3 2020$39
-13.3%
150.0%0.00%
Q2 2020$45
+55.2%
150.0%0.00%
Q1 2020$29
-73.6%
150.0%0.00%
Q4 2019$110
+61.8%
150.0%0.00%
Q3 2019$68
-54.7%
150.0%0.00%
Q2 2019$150
-14.3%
150.0%0.00%
Q1 2019$175
-2.8%
150.0%0.00%
Q4 2018$180
-29.7%
150.0%0.00%
Q3 2018$2560.0%150.0%0.00%
Q2 2018$256150.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Clal Insurance Enterprises Holdings Ltd 4,306$585,000,0000.63%
DAFNA Capital Management LLC 205,825$1,515,0000.52%
MENORA MIVTACHIM HOLDINGS LTD. 2,094,208$15,413,0000.37%
Altshuler Shaham Ltd 1,095,018$8,060,0000.23%
MEITAV INVESTMENT HOUSE LTD 338,655$2,493,0000.18%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 125,900$927,0000.01%
HRT FINANCIAL LP 23,214$170,0000.01%
Squarepoint Ops LLC 63,736$469,0000.00%
Paloma Partners Management Co 16,318$120,0000.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 152,932$1,126,0000.00%
View complete list of ELOXX PHARMACEUTICALS INC shareholders